Clinical Trial Update: The Effect of Sacubitril/valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients with Ischemic Heart Failure with Mid-range Ejection Fraction [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing sacubitril/valsartan to ramipril in ischemic heart failure with mid-range ejection fraction is currently recruiting to evaluate effect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Mid-range Ejection Fraction
• Ischemic Cardiomyopathy

Drugs mentioned

• Entresto (sacubitril/valsartan)
• Ramipril (ramipril)

Snippet

Sponsor: John Paul II Hospital, Krakow | Conditions: Heart Failure with Moderately Reduced Ejection Fraction | Phase 3 | Status: RECRUITING